Clinical Trial Update: Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC [Phase 1]

View source ↗

Summary

A Phase I study evaluating active breathing control with simultaneous boost for non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Large Cell Lung Cancer
• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Adenocarcinoma of the Lung, Large Cell Lung Cancer | Phase 1 | Status: WITHDRAWN